Novel biomaterial strategies for controlled growth factor delivery for biomedical applications

TLDR: This review evaluates the latest techniques in direct immobilization and relevant biomaterials used for GF loading and release, including synthetic polymers, albumin, polysaccharides, lipids, mesoporous silica-based nanoparticles (NPs), and polymeric capsules and focuses on GF-encapsulated NPs in functionalized microporous scaffolds as a promising alternative.

Abstract: Growth factors (GFs) are soluble proteins secreted by cells that have the ability to regulate a variety of cellular processes and tissue regeneration. However, their translation into clinical applications is limited due to their short effective half-life, low stability, and rapid inactivation by enzymes under physiological conditions. To maximize the effectiveness of GFs and their biologically relevant applicability, a wide variety of sophisticated bio-inspired systems have been developed that augment tissue repair and cellular regeneration by controlling how much, when, and where GFs are released. Recently, protein immobilization techniques combined with nanomaterial carriers have shown promise in mimicking the natural healing cascade during tissue regeneration by augmenting the delivery and effectiveness of GFs. This review evaluates the latest techniques in direct immobilization and relevant biomaterials used for GF loading and release, including synthetic polymers, albumin, polysaccharides, lipids, mesoporous silica-based nanoparticles (NPs), and polymeric capsules. Specifically, we focus on GF-encapsulated NPs in functionalized microporous scaffolds as a promising alternative with the ability to mimic extracellular matrix (ECM) hierarchical architectures and components with high cell affinity and bioactivity. Finally, we discuss how these next-generation, advanced delivery systems have been used to enhance tissue repair and regeneration and consider future implications for their use in the field of regenerative medicine. Nanomaterials can speed up the rate at which wounds heal and tissue regenerates. Songlin Peng from the Jinan University Second College of Medicine, China, and colleagues review the development of artificial materials that achieve this aim by mimicking the hierarchical architecture of the extracellular matrix. Cells can proliferate and migrate by secreting proteins that signal to adjacent cells. These proteins – known as growth factors – bind to specific receptors on the target cell. But it is difficult to harness this simple concept in clinical applications such as wound healing because the instability of growth factors limits their safety and cost effectiveness. Peng and co-workers review recent progress in the use of functionalized microporous scaffolds functionalized with growth factor encapsulated nanoparticles. They also outline its advantages over alternative approaches employing polymers, lipids and mesoporous silica-based nanoparticles. Schematic illustration of Biomaterial Strategies for Controlled Growth Factor (GF) Delivery for Biomedical Applications. (a) The direct approaches for the immobilization/encapsulation of GFs to biomaterials; (b) Nanocarriers for GFs encapsulation and release; (c) GFs encapsulated nanocarriers functionalized biomaterials for tissue regeneration.